Literature DB >> 10846079

Cellular and viral specificities of human immunodeficiency virus type 1 vif protein.

N Madani1, D Kabat.   

Abstract

The vif gene of human immunodeficiency virus type 1 (HIV-1) greatly enhances the infectivity of HIV-1 virions that are released from cells classified as nonpermissive (e.g., lymphocytes, macrophages, and H9 leukemic T cells) but is irrelevant in permissive cells (e.g., HeLa or COS cells). Recently, it was reported that vif expression in nonpermissive cells dramatically increases infectivity not only of HIV-1 but also of other enveloped viruses, including murine leukemia viruses (MLVs). This was surprising in part because MLVs and other murine retroviruses lack vif genes yet replicate efficiently in T lymphocytes. To investigate these issues, we first developed improved methods for producing substantial quantities of HIV-1 virions with vif deletions from healthy H9 cells. These virions had approximately the same amounts of major core proteins and envelope glycoproteins as the control wild-type virions but were only approximately 1% as infectious. We then produced H9 cells that contained wild-type or vif deletion HIV-gpt proviruses, which lack a functional env gene. After superinfection with either xenotropic or amphotropic MLVs, these cells released HIV-gpt virions pseudotyped with an MLV envelope plus replication-competent MLV. Interestingly, the pseudotyped HIV-gpt (vif deletion) virions were noninfectious, whereas the MLV virions simultaneously released from the same H9 cells were fully infectious. These results strongly suggest that the Vif protein functions in a manner that is both cell specific and at least substantially specific for HIV-1 and related lentiviruses. In addition, these results confirm that vif deletion HIV-1 virions from nonpermissive cells are blocked at a postpenetration stage of the infection pathway.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10846079      PMCID: PMC112094          DOI: 10.1128/jvi.74.13.5982-5987.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

Review 1.  HIV accessory proteins: leading roles for the supporting cast.

Authors:  D Trono
Journal:  Cell       Date:  1995-07-28       Impact factor: 41.582

2.  Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein.

Authors:  M K Karczewski; K Strebel
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

3.  The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes.

Authors:  J H Simon; M H Malim
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  Infectious properties of human immunodeficiency virus type 1 mutants with distinct affinities for the CD4 receptor.

Authors:  E J Platt; N Madani; S L Kozak; D Kabat
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

5.  Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins.

Authors:  R A Fouchier; J H Simon; A B Jaffe; M H Malim
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

6.  Biological activity of human immunodeficiency virus type 1 Vif requires membrane targeting by C-terminal basic domains.

Authors:  J Goncalves; B Shi; X Yang; D Gabuzda
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes.

Authors:  J H Simon; T E Southerling; J C Peterson; B E Meyer; M H Malim
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

8.  Interferon treatment inhibits virus replication in HIV-1- and SIV-infected CD4+ T-cell lines by distinct mechanisms: evidence for decreased stability and aberrant processing of HIV-1 proteins.

Authors:  M B Agy; R L Acker; C H Sherbert; M G Katze
Journal:  Virology       Date:  1995-12-20       Impact factor: 3.616

9.  Rapid induction of apoptosis by cell-to-cell transmission of human immunodeficiency virus type 1.

Authors:  F Maldarelli; H Sato; E Berthold; J Orenstein; M A Martin
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

10.  Peripheral blood mononuclear cells produce normal amounts of defective Vif- human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps.

Authors:  M Courcoul; C Patience; F Rey; D Blanc; A Harmache; J Sire; R Vigne; B Spire
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

View more
  15 in total

1.  Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.

Authors:  P Sova; D J Volsky; L Wang; W Chao
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Mass spectrometry analysis of HIV-1 Vif reveals an increase in ordered structure upon oligomerization in regions necessary for viral infectivity.

Authors:  Jared R Auclair; Karin M Green; Shivender Shandilya; James E Evans; Mohan Somasundaran; Celia A Schiffer
Journal:  Proteins       Date:  2007-11-01

3.  Small-molecule inhibition of HIV-1 Vif.

Authors:  Robin Nathans; Hong Cao; Natalia Sharova; Akbar Ali; Mark Sharkey; Ruzena Stranska; Mario Stevenson; Tariq M Rana
Journal:  Nat Biotechnol       Date:  2008-09-21       Impact factor: 54.908

Review 4.  Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation.

Authors:  Sonia Shah; Michael R Nonnemacher; Vanessa Pirrone; Brian Wigdahl
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

5.  Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus.

Authors:  Susan L Kozak; Jean Michel Heard; David Kabat
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

6.  Movements of HIV-1 genomic RNA-APOBEC3F complexes and PKR reveal cytoplasmic and nuclear PKR defenses and HIV-1 evasion strategies.

Authors:  Mariana Marin; Sheetal Golem; Susan L Kozak; David Kabat
Journal:  Virus Res       Date:  2015-11-25       Impact factor: 3.303

7.  Susceptibility of rat-derived cells to replication by human immunodeficiency virus type 1.

Authors:  O T Keppler; W Yonemoto; F J Welte; K S Patton; D Iacovides; R E Atchison; T Ngo; D L Hirschberg; R F Speck; M A Goldsmith
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

8.  HIV-1 Vif and APOBEC3G: multiple roads to one goal.

Authors:  Joao Goncalves; Mariana Santa-Marta
Journal:  Retrovirology       Date:  2004-09-21       Impact factor: 4.602

9.  Direct participation of Sam68, the 68-kilodalton Src-associated protein in mitosis, in the CRM1-mediated Rev nuclear export pathway.

Authors:  Jinliang Li; Ying Liu; Byung Oh Kim; Johnny J He
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  Characterization of producer cell-dependent restriction of murine leukemia virus replication.

Authors:  Fatima Serhan; Nathalie Jourdan; Sylvie Saleun; Philippe Moullier; Ghislaine Duisit
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.